Vimarsana
Biggest News Aggregation in the World

Page 19 - Michael Berger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Berger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Berger Today - Breaking & Trending Today

Canopy Growth Sells Skincare & Wellness Brand For $11.7M, Streamlines Focus To Cannabis - Canopy Gwth (NASDAQ:CGC) - Vimarsana News

Canopy Growth Sells Skincare & Wellness Brand For $11.7M, Streamlines Focus To Cannabis - Canopy Gwth (NASDAQ:CGC)

Cannabis firm Canopy Growth sold its skincare and wellness brand, opting to focus on "a simplified, asset-light, cannabis-focused business."

Colombia's President Wants Weed Legalized Despite Senate Opposition: Prohibition Increases 'Profits Of Drug Trafficking, Violence' - Clever Leaves Holdings (NASDAQ:CLVRW), Clever Leaves Holdings (NASDAQ:CLVR) - Vimarsana News

Colombia's President Wants Weed Legalized Despite Senate Opposition: Prohibition Increases 'Profits Of Drug Trafficking, Violence' - Clever Leaves Holdings (NASDAQ:CLVRW), Clever Leaves Holdings (NASDAQ:CLVR)

The Colombian Senate has put on hold a measure seeking to legalise marijuana, despite it having advanced through the Chamber of Representatives and a Senate committee. Colombian President Gustavo Petro objected to the decision, arguing that it would increase the profits of drug trafficking and its violence. If lawmakers decide to implement the reform, they will have to start the two-year legislative process from scratch next year.

SEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials - Cannabis Bioscience (OTC:CBIH) - Vimarsana News

SEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials - Cannabis Bioscience (OTC:CBIH)

Cannabis Bioscience, a Houston-based clinical research company, has announced plans to conduct cannabis clinical trials using artificial intelligence (AI) programs. The company aims to optimize the research processes and promote the use of cannabinoid therapies as a first option for patients. Proceeds from a stock offering by selling shareholders will be used to fund these trials.

New York Will Get 12 New Weed Dispensaries, Ending 2023 With More Than 35 Adult-Use Stores Open - Acreage Holdings (OTC:ACRDF), Cannabist Holdings (OTC:CBSTF) - Vimarsana News

New York Will Get 12 New Weed Dispensaries, Ending 2023 With More Than 35 Adult-Use Stores Open - Acreage Holdings (OTC:ACRDF), Cannabist Holdings (OTC:CBSTF)

New York governor Kathy Hochul has announced plans to open a dozen new recreational cannabis dispensaries, including eight Black-owned, five Hispanic-owned and nine women-owned. In total, New York is expecting to have 37 stores selling adult-use cannabis by the end of December. A New York Supreme Court decision that lifted an injunction blocking cannabis dispensary licenses earlier this month resulted in licenses being granted to companies like PharmCann, NYCANNA and The Cannabist Company Holdings, the latter previously known as Columbia Care.

Drive-Thru Cannabis Sales Help C21: Same-Store Sales Up, But Revenue Down In Q3 - C21 Investments (OTC:CXXIF) - Vimarsana News

Drive-Thru Cannabis Sales Help C21: Same-Store Sales Up, But Revenue Down In Q3 - C21 Investments (OTC:CXXIF)

C21 Investments reported a 4.5% year-over-year and a 3.9% sequential decrease in revenue to $6.9 million for the third quarter ended October 31. The Vancouver-based company also reported a sequential increase in same-store sales. Gross profit totaled $2.7 million, down from $3.9 million in the prior year's quarter, and the net loss was $376,150 compared to net income of $248,507 in the same period last year. C21 Investments generated $0.9 million of adjusted EBITDA, unchanged from the prior quarter, and cash at the end of Q3 was $1.9 million, unchanged since the start of the year.